ChanRx
Cleveland, US · Delaware corporation · 2 known investors
Biotech
Founders & leadership
KL
Kevin LalandeDirector
HD
Howard DittrichExecutive Officer
RB
Robert Baltera, Jr.Executive Officer, Director
JD
Jerel DavisDirector
JT
James TopperDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$4.5MraisedJul 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedJul 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin LalandeDirector
- James TopperDirector
- Robert Baltera, Jr.Executive Officer, Director
- Brian FarmerExecutive Officer
- Jerel DavisDirector
- Howard DittrichExecutive Officer
- Offering amount
- $4.7M
- Amount sold
- $4.5M
- First sale
- Nov 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.6MraisedFeb 2015 · 18 investors · PharmaceuticalsRule 506(b)
▶$16.6MraisedFeb 2015 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin LalandeDirector
- Howard DittrichExecutive Officer
- Robert Baltera, Jr.Executive Officer, Director
- Jerel DavisDirector
- James TopperDirector
- Offering amount
- $31.9M
- Amount sold
- $16.6M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.